In addition, in the case of melanoma and non-small cell lung cancer (NSCLC) [63], the level of PD-L1 in plasma-derived exosomes was substantially lower in patients with treatment response and higher in patients with disease progression, while no significant changes were observed in patients with stable disease (SD) [63]. Here, CD274 is linked to non-small cell lung carcinoma.